Estrogen deficiency and bone loss: an inflammatory tale.
暂无分享,去创建一个
[1] T. Fry,et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. , 2001, Blood.
[2] M. Nanes. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. , 2003, Gene.
[3] G. Gronowicz,et al. Interleukin‐7 Influences Osteoclast Function In Vivo but Is Not a Critical Factor in Ovariectomy‐Induced Bone Loss , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] G. Mundy,et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β , 1996, Nature Medicine.
[5] J. Bijlsma,et al. Interleukin 7 stimulates tumour necrosis factor α and Th1 cytokine production in joints of patients with rheumatoid arthritis , 2003, Annals of the rheumatic diseases.
[6] R. Pacifici,et al. The role of T lymphocytes in bone metabolism , 2005, Immunological reviews.
[7] J. Compston,et al. Bone Remodeling and Structure in Postmenopausal Women Treated with Long-Term, High-Dose Estrogen Therapy , 1999, Osteoporosis International.
[8] S. Teitelbaum,et al. Bone resorption by osteoclasts. , 2000, Science.
[9] M. Nanes. Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology , 2003 .
[10] R. Koup,et al. Evidence for thymic function in the elderly. , 2000, Vaccine.
[11] Wei-Ping Qian,et al. An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Jensen,et al. Transcriptional regulation of the MHC class II antigen presentation pathway. , 2003, Current opinion in immunology.
[13] M. Almeida,et al. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. , 2003, The Journal of clinical investigation.
[14] P. Marrack,et al. Reactive oxygen species regulate activation-induced T cell apoptosis. , 1999, Immunity.
[15] S. Khosla,et al. Minireview: the OPG/RANKL/RANK system. , 2001, Endocrinology.
[16] Sundeep Khosla,et al. Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.
[17] T. Martin,et al. Activated T lymphocytes support osteoclast formation in vitro. , 1999, Biochemical and biophysical research communications.
[18] J. Pfeilschifter,et al. Changes in proinflammatory cytokine activity after menopause. , 2002, Endocrine reviews.
[19] R. Ceredig,et al. Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis. , 1996, Experimental hematology.
[20] S. Manolagas,et al. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.
[21] F. Pei,et al. Different Doses of Nitric Oxide Donor Prevent Osteoporosis in Ovariectomized Rats , 2005, Clinical orthopaedics and related research.
[22] Chendong Yang,et al. Generation and Function of Reactive Oxygen Species in Dendritic Cells During Antigen Presentation 1 , 2003, The Journal of Immunology.
[23] M. Nagarkatti,et al. Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. , 2001, Toxicology.
[24] S. Cummings,et al. Isosorbide Mononitrate Increases Bone Formation and Decreases Bone Resorption in Postmenopausal Women: A Randomized Trial , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] R. Pacifici,et al. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. , 2002, The Journal of clinical investigation.
[26] Xiaofei He,et al. Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-α. , 2000, Endocrinology.
[27] Oscar L. Sierra,et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-γ-induced class II transactivator , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] Wei-Ping Qian,et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor κB ligand and tumor necrosis factor α from T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] N. Kamatani,et al. IFN‐γ‐producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL , 2005, European journal of immunology.
[30] Hong-Hee Kim,et al. Reactive oxygen species mediate RANK signaling in osteoclasts. , 2004, Experimental cell research.
[31] F. Ross,et al. Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation* , 2001, The Journal of Biological Chemistry.
[32] Masaki Noda,et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.
[33] W. McBride,et al. Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7. , 1995, Journal of the National Cancer Institute.
[34] H. Beck-Nielsen,et al. Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra. , 1997, Bone.
[35] M. Bouxsein,et al. Ovariectomy‐Induced Bone Loss Varies Among Inbred Strains of Mice , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] T. Taniguchi,et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. , 2000, Nature.
[37] S. Ralston,et al. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] A. Marušić,et al. Depletion of CD4 and CD8 T Lymphocytes in Mice In Vivo Enhances 1,25-Dihydroxyvitamin D3-Stimulated Osteoclast-Like Cell Formation In Vitro by a Mechanism That Is Dependent on Prostaglandin Synthesis1 , 2000, The Journal of Immunology.
[39] J. Wit,et al. The Role of Estrogen in the Control of Rat Osteocyte Apoptosis , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] D. Roopenian,et al. CD4+ T Cells and the Proinflammatory Cytokines Gamma Interferon and Interleukin-6 Contribute to Alveolar Bone Loss in Mice , 1999, Infection and Immunity.
[41] M. Tohkin,et al. Comparative study of inhibitory effects by murine interferon γ and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK) , 1994, Cancer Immunology, Immunotherapy.
[42] R. Pacifici,et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. , 2000, The Journal of clinical investigation.
[43] Z. Urry,et al. Thioredoxin-1 mediates osteoclast stimulation by reactive oxygen species. , 2004, Biochemical and biophysical research communications.
[44] J. Gustafsson,et al. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.
[45] D. Lacey,et al. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. , 1999, Bone.
[46] J. Milbrandt,et al. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. , 1998, The Journal of clinical investigation.
[47] B. Komm,et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. , 1988, Science.
[48] A. Martini,et al. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. , 1995, The Journal of rheumatology.
[49] H. Fox,et al. Estrogen regulates the IFN-gamma promoter. , 1991, Journal of immunology.
[50] K. Michaëlsson,et al. Association between oxidative stress and bone mineral density. , 2001, Biochemical and biophysical research communications.
[51] G. Haegeman,et al. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. , 1999, Journal of immunology.
[52] J. Haug,et al. T Cell Activation Induces Human Osteoclast Formation via Receptor Activator of Nuclear Factor κB Ligand‐Dependent and ‐Independent Mechanisms , 2001 .
[53] M. Catani,et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. , 2003, The Journal of clinical endocrinology and metabolism.
[54] C. Murphy,et al. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. , 2002, Endocrinology.
[55] R. Koup,et al. Generation of functional thymocytes in the human adult. , 1999, Immunity.
[56] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[57] W. V. Berghe,et al. N-Acetyl-l-Cysteine Inhibits Primary Human T Cell Responses at the Dendritic Cell Level: Association with NF-κB Inhibition , 1999, The Journal of Immunology.
[58] Z. Grossman,et al. Self-tolerance: context dependent tuning of T cell antigen recognition. , 2000, Seminars in immunology.
[59] F. Lemonnier,et al. Differential requirements for survival and proliferation of CD8 naïve or memory T cells. , 1997, Science.
[60] R. Guldberg,et al. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[61] R. Maki,et al. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. , 1990, Journal of immunology.
[62] S. Takao,et al. Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells , 2005, Immunology and cell biology.
[63] C. Murphy,et al. TNFα Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL. , 2002, Endocrinology.
[64] Ilangovan Ramachandran,et al. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[65] S. Nakagawa,et al. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. , 2005, The Journal of investigative dermatology.
[66] H. Müller-Hermelink,et al. The Involution of the Ageing Human Thymic Epithelium is Independent of Puberty , 1985, Scandinavian journal of immunology.
[67] R. Rodriguiz,et al. Combination Macrophage-Colony Stimulating Factor and Interferon-γ Administration Ameliorates the Osteopetrotic Condition in Microphthalmic (mi/mi) Mice , 1993, Pediatric Research.
[68] F. Ross,et al. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. , 1999, The Journal of clinical investigation.
[69] M. Sorci-Thomas,et al. Estrogen modulates the expression of tumor necrosis factor alpha mRNA in phorbol ester-stimulated human monocytic THP-1 cells. , 1994, Lymphokine and cytokine research.
[70] T. Chambers,et al. Tumor Necrosis Factor-α Mediates Osteopenia Caused by Depletion of Antioxidants , 2005 .
[71] Wei-Ping Qian,et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[72] D. Lacey,et al. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells , 1999 .
[73] B. Chain,et al. Reactive oxygen species activate human peripheral blood dendritic cells. , 1999, Free radical biology & medicine.
[74] A. Billiau,et al. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. , 1997, Journal of immunology.
[75] N. Andersson,et al. Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss. , 2006, Bone.
[76] R. Bataille,et al. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. , 2002, Blood.
[77] R. Rodriguiz,et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. , 1995, The New England journal of medicine.
[78] Josef M. Penninger,et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand , 1999, Nature.
[79] T. Heng,et al. Activation of Thymic Regeneration in Mice and Humans following Androgen Blockade , 2005, The Journal of Immunology.
[80] Min Huang,et al. IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis , 2002 .
[81] Gregory D. Sempowski,et al. The human thymus during aging , 2000, Immunologic research.
[82] S. Nozawa,et al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. , 1994, The Journal of clinical investigation.
[83] Bert W O'Malley,et al. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. , 2004, Endocrine reviews.
[84] J. Gerdes,et al. Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. , 1990, The American journal of pathology.
[85] K. Ikeda,et al. Generation of Bone‐Resorbing Osteoclasts from B220+ Cells: Its Role in Accelerated Osteoclastogenesis due to Estrogen Deficiency * , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[86] C. Yallampalli,et al. Nitric oxide donor alleviates ovariectomy-induced bone loss. , 1996, Bone.
[87] R. Kimble,et al. The Functional Block of TNF but Not of IL‐6 Prevents Bone Loss in Ovariectomized Mice , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[88] T. Chambers,et al. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. , 2005, Endocrinology.
[89] B. L. Riggs,et al. Drugs Used to Treat Osteoporosis: The Critical Need for a Uniform Nomenclature Based on Their Action on Bone Remodeling , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[90] N. Takahashi,et al. Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice. , 1992, Cancer research.
[91] E. Benveniste,et al. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. , 2004, Molecular endocrinology.
[92] T. Chambers,et al. Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants. , 2005, Endocrinology.
[93] J. Rungby,et al. Hormone Replacement Therapy Prevents Osteoclastic Hyperactivity: A Histomorphometric Study in Early Postmenopausal Women , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[94] B. Katzenellenbogen,et al. Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity , 2001, Cell.
[95] M. Karnovsky,et al. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone , 1994, The Journal of cell biology.
[96] A. Glasebrook,et al. Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene , 1996, Science.
[97] J. Rubin,et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. , 2000, Endocrinology.
[98] Hiroshi Takayanagi,et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ , 2000, Nature.
[99] P. Roberson,et al. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. , 1998, The Journal of clinical investigation.
[100] S. Takeshita,et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. , 2000, The Journal of clinical investigation.
[101] D. Kioussis,et al. A self-reactive T cell population that is not subject to negative selection. , 1992, International immunology.
[102] D. McDonnell,et al. The Estrogen Receptor -isoform (er) of the Human Estrogen Receptor Modulates Er␣ Transcriptional Activity and Is a Key Regulator of the Cellular Response to Estrogens and Antiestrogens* , 2022 .
[103] J. Haug,et al. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[104] B. Riggs,et al. Avian osteoclasts as estrogen target cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[105] R. Jilka,et al. Sex steroids and bone. , 2002, Recent progress in hormone research.
[106] M. Perales,et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. , 2001, Blood.
[107] R. Baron,et al. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. , 2003, The Journal of clinical investigation.
[108] R. Pacifici,et al. Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[109] Z. Urry,et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. , 2003, The Journal of clinical investigation.
[110] M. Eckhaus,et al. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. , 2004, Blood.
[111] Kozo Nakamura,et al. Connection Between B Lymphocyte and Osteoclast Differentiation Pathways1 , 2001, The Journal of Immunology.
[112] A. Mukherjee,et al. Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways* , 2001, The Journal of Biological Chemistry.
[113] E. Schwarz,et al. Exposure to receptor-activator of NFκB ligand renders pre-osteoclasts resistant to IFN-γ by inducing terminal differentiation , 2002, Arthritis research & therapy.
[114] B Stein,et al. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.
[115] V. Verhasselt,et al. Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory T cells , 2003, Transplantation.
[116] Li Han,et al. Transient Versus Sustained Phosphorylation and Nuclear Accumulation of ERKs Underlie Anti-Versus Pro-apoptotic Effects of Estrogens* , 2005, Journal of Biological Chemistry.
[117] R. Rizzoli,et al. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. , 1997, The Journal of clinical investigation.
[118] K. Hirokawa,et al. Hypertrophy of the thymus and restoration of immune functions in mice and rats by gonadectomy , 1989, Mechanisms of Ageing and Development.
[119] K. Ikuta,et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[120] Y. Kadono,et al. Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis , 2005, The Journal of experimental medicine.
[121] R. Eastell,et al. Cancellous bone remodeling in type i (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[122] Shi Wei,et al. IL-1 mediates TNF-induced osteoclastogenesis. , 2005, The Journal of clinical investigation.
[123] Michael Reth,et al. Hydrogen peroxide as second messenger in lymphocyte activation , 2002, Nature Immunology.
[124] C. Mackall,et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults , 2005 .
[125] M. Anbar,et al. Effects of Natural Menopause, Hysterectomy, and Oophorectomy on Lumbar Spine and Femoral Neck Bone Densities , 1988, Obstetrics and gynecology.
[126] R. Pacifici,et al. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. , 2000, Blood.
[127] B. Leibovich,et al. Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation1 , 2004, The Journal of Immunology.
[128] H. Rammensee,et al. Peptides naturally presented by MHC class I molecules. , 1993, Annual review of immunology.
[129] E. Puscheck,et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.